Novel psilocin derivatives having prodrug properties
NZ836196APending Publication Date: 2026-08-28COMPASS PATHFINDER LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- NZ836196
- Authority / Receiving Office
- NZ · NZ
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2020-11-27
- Filing Date
- 2021-08-23
- Publication Date
- 2026-08-28
Smart Images
Figure 00000050_0000 
Figure 00000050_0001 
Figure 00000051_0000
Abstract
The present invention provides a novel group of active compounds based on the psychoactive compound psilocin. The psilocin derivatives provided herein exhibit improved pharmacokinetic properties during uptake as compared to psilocin, as well as reduced side effects resulting from the metabolites thus formed. Due to the affinity of the novel psilocin derivatives for the 5-HT 2A- receptor, these derivatives are particularly advantageous for use in therapy, e.g., in the treatment of depression or drug addiction.
Need to check novelty before this filing date? Find Prior Art